We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Contracts With Emergent BioSolutions for its COVID-19 Vaccine
AstraZeneca Contracts With Emergent BioSolutions for its COVID-19 Vaccine
Maryland-based Emergent BioSolutions has signed an $87 million contract with AstraZeneca to support development and production of the UK company’s COVID-19 vaccine, one of the leading candidates in the global race for an effective product.